financetom
Business
financetom
/
Business
/
Intuitive Surgical Insider Sold Shares Worth $1,136,850, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intuitive Surgical Insider Sold Shares Worth $1,136,850, According to a Recent SEC Filing
Nov 6, 2025 11:35 AM

02:23 PM EST, 11/06/2025 (MT Newswires) -- Fredrik Widman, Vice President, Corporate Controller, on November 05, 2025, sold 2,067 shares in Intuitive Surgical ( ISRG ) for $1,136,850. Following the Form 4 filing with the SEC, Widman has control over a total of 473 common shares of the company, with 473 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1035267/000189797025000003/xslF345X05/edgardoc.xml

Price: 547.34, Change: -1.21, Percent Change: -0.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Beazer Homes Amends, Expands Revolving Credit Facility to $525 Million
Beazer Homes Amends, Expands Revolving Credit Facility to $525 Million
Mar 17, 2026
04:56 PM EDT, 03/17/2026 (MT Newswires) -- Beazer Homes USA ( BZH ) said late Tuesday it has entered into a third amendment to its current senior unsecured revolving credit facility, raising the available commitment amount by $160 million to $525 million. The amendment also extends the maturity date of the credit facility from March 15, 2028, to March 13,...
Myriad Genetics Gets US FDA Approval of MyChoice as Companion Diagnostic for Ovarian Cancer Drug
Myriad Genetics Gets US FDA Approval of MyChoice as Companion Diagnostic for Ovarian Cancer Drug
Mar 17, 2026
04:56 PM EDT, 03/17/2026 (MT Newswires) -- Myriad Genetics ( MYGN ) said Tuesday the US Food and Drug Administration has approved the MyChoice test as the companion diagnostic for GSK's (GSK) Zejula for patients with ovarian cancer. MyChoice CDx is the only FDA-approved companion test in the US to identify people with homologous recombination deficiency-positive status eligible for treatment...
Auburn National Bancorporation Authorizes Stock Repurchase Program
Auburn National Bancorporation Authorizes Stock Repurchase Program
Mar 17, 2026
AUBURN, Ala., March 17, 2026 (GLOBE NEWSWIRE) -- Auburn National Bancorporation, Inc. ( AUBN ) announced today that the Company’s Board of Directors has approved a new stock repurchase program. The Company’s prior stock repurchase program expired April 15, 2024. The new program authorizes the repurchase, from time to time, of up to $5 million of the Company’s issued and...
Contango Stockholders Overwhelmingly Approve Merger with Dolly Varden
Contango Stockholders Overwhelmingly Approve Merger with Dolly Varden
Mar 17, 2026
FAIRBANKS, Alaska, March 17, 2026 /PRNewswire/ - Contango ORE, Inc. ( CTGO ) (Contango or the Company) is pleased to announce that at the special meeting (the Special Meeting) of Contango stockholders held today, Contango stockholders overwhelmingly approved all three proposals voted on at the Special Meeting. Any capitalized terms which are used herein but not defined have the meanings...
Copyright 2023-2026 - www.financetom.com All Rights Reserved